EX-10 6 filename6.htm Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. CONFIDENTIAL UNIVERSITY of PENNSYLVANIA Patent License AgreementStockholders Agreement • May 5th, 2020 • Pennsylvania
Contract Type FiledMay 5th, 2020 JurisdictionThis Patent License Agreement (this “Agreement”) is between The Trustees of the University of Pennsylvania, a Pennsylvania nonprofit corporation (“Penn”), and Apellis AG, a company organized and existing under the laws of Switzerland (“Company”). This Agreement is being entered into by and between Penn and Company on March 28, 2008 (the “Effective Date”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. CONFIDENTIAL UNIVERSITY of PENNSYLVANIA Patent License AgreementStockholders Agreement • October 13th, 2017 • Apellis Pharmaceuticals, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledOctober 13th, 2017 Company Industry JurisdictionTHIS THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this “Agreement”) is entered into as of March , 2008, by and among Potentia Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and those individuals identified on Exhibit A hereto (individually, each a “Stockholder” and collectively, the “Stockholders”).
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. CONFIDENTIAL UNIVERSITY of PENNSYLVANIA Patent License AgreementStockholders Agreement • October 13th, 2015 • Apellis Pharmaceuticals, Inc. • Pharmaceutical preparations • Pennsylvania
Contract Type FiledOctober 13th, 2015 Company Industry JurisdictionTHIS THIRD AMENDED AND RESTATED STOCKHOLDERS AGREEMENT (this “Agreement”) is entered into as of March , 2008, by and among Potentia Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and those individuals identified on Exhibit A hereto (individually, each a “Stockholder” and collectively, the “Stockholders”).